Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

Morgan Lewis represented Cyclerion Therapeutics in the transaction.Cyclerion Therapeutics Inc. closed a licensing agreement with Akebia Therapeutics Inc. for the development and commercialization of praliciguat, an…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now